MAUREEN LUBAS: Open Payments
NPI 1083084040 · MEDIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 13 payments from 11 companies in 2025. Trend: 2023 $922 · 2024 $2,795 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $136 |
| Gilead Sciences, Inc. | 1 | $128 |
| PFIZER INC. | 1 | $114 |
| Neurelis, Inc. | 1 | $101 |
| GlaxoSmithKline, LLC. | 1 | $101 |
| Cipher Pharmaceuticals US LLC | 1 | $99 |
| Phathom Pharmaceuticals, Inc. | 1 | $89 |
| KYOWA KIRIN, INC. | 1 | $87 |
| ARGENX US, INC. | 1 | $30 |
| ACADIA Pharmaceuticals Inc | 2 | $29 |
Products named: REXULTI, Descovy, PREVNAR 20, VALTOCO, NUCALA, Natroba, VOQUEZNA, VYVGART HYTRULO.
Industry payments across PA — which companies pay providers there.
